Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma

Correction to: Leukemiahttps://doi.org/10.1038/s41375-025-02777-2, published online 07 October 2025 In the originally published version of this article, same minor errors were present: (1) in Table 1, only the headers should appear in bold font, as now corrected; (2) in Figure 1B, two typographical errors occurred in panels c and d, where the correct legends are MEITL No 030 and MEITL No 039 instead of EATL No 030 and EATL No 039; (3) in Figure 3B, the MEITL CNV profile was mistakenly replaced by a duplication of the EATL profile. The correct MEITL profile has been now inserted; (4) in Figure 4F, the miRNA “577” label appeared in green font instead of black. All errors have been corrected in the revised figures and table provided in the updated version. Incorrect figure 1 (Figure presented.) Corrected figure 1 (Figure presented.) Incorrect figure 3 (Figure presented.) Corrected figure 3 (Figure presented.) Incorrect figure 4 (Figure presented.) Corrected figure 4 (Figure presented.) (Table presented.) MEITL (n = 52) EATL (n = 30) p value Reported celiac disease 0/52 (0%) 13/30 (43%) Age, median, years (range, median) 67 (29-91) 64 (34-86) 0.37 Gender (male/female) 27:25:00 19:11 0.2 Acute event at presentation 38/44 (86%) 12/18 (67%) 0.09 Bowel perforation 33/44 (75%) 8/18 (44%) Bowel obstruction 12/44 (27%) 6/18 (33%) 0.76 Lugano stage Stage I/II 27/44 (61%) 8/13 (61%) 1 Stage III/IV 17/44 (39%) 5/13 (39%) PS 0-1 18/40 (45%) 4/8 (50%) 1 ≥2 22/40 (55%) 4/8 (50%) Typical 31/52 (60%) Atypical 21/52 (40%) Pleomorphic 13/52 (25%) 30/30 (100%) Anaplastic 1/52 (2%) 15/30 (50%) Necrosis 7/52 (13%) 22/30 (73%) Starry-sky 5/52 (10%) 3/30 (10%) 1 Angiotropism 14/51 (27%) 19/29 (65%) Epitheliotropism 36/41 (88%) 2/20 (10%) Moderate/abundant inflammation 3/52 (6%) 20/30 (67%) CD8 47/52 (90%) 4/30 (13%) CD56 46/52 (88%) 2/28 (7%) CD3 52/52 (100%) 27/30 (90%) CD2 20/47 (42%) 12/24 (50%) 0.619 CD5 2/51 (4%) 2/30 (7%) 0.624 CD7 48/48 (100%) 22/23 (96%) 0.324 CD4 2/52 (4%) 2/27 (7%) 0.603 CD103 40/51 (78%) 15/25 (60%) 0.108 CD30 0/47 (0%) 25/29 (86%) TIA1 47/52 (90%) 20/25 (80%) 0.108 Granzyme B 37/52 (71%) 19/28 (68%) 0.596 Perforin 27/52 (52%) 22/29 (76%) CD20 9/49 (18%) 1/29 (3%) CD79a 3/41 (7%) 0/10 (0%) 0.567 TCRβ 17/50 (34%) 8/28 (29%) 0.472 TCRγδ 26/50 (52%) 8/27 (30%) TCRαβ-TCRγδ+ 22/49 (44%) 4/26 (15%) TCRαβ+TCRγδ- 12/49 (24%) 4/26 (15%) 0.391 TCRαβ+TCRγδ+ 4/49 (8%) 3/26 (11%) 0.685 TCRαβ-TCRγδ- 11/49 (22%) 15/26 (58%) The original article has been corrected.

Authors

Institutions

Publication Details

Journal
Leukemia
Published
2025-11-20
DOI
https://doi.org/10.1038/s41375-025-02808-y
Primary Topic
Celiac Disease Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma

Philippe Gaulard, Luis Veloza, Christophe Bonnet, Joan Somja et al.
Leukemia
Celiac Disease Research and Management
article

Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma

Philippe Gaulard, Luis Veloza, Christophe Bonnet, Joan Somja, David Vallois, Anja Fischer, Leticia Quintanilla-Martı́nez, Reiner Siebert, Julie Bruneau, Kamel Laribi, Jérémy Sandrini, Rita Sarkis, François Lemonnier, Albane Ledoux‐Pilon, Luc Xerri, Elsa Poullot, Pierre Morel, Edoardo Missiaglia, Olivier Tournilhac, Emmanuel Bachy, Vincent Roh, Vimel Rattina, Romain Dubois, Laura Wiehle, Bettina Bisig, Virginie Fataccioli, Fanny Drieux, Jean‐François Emile, Laurence de Leval, Doriane Cavalieri, Anne Cairoli, Roland de Wind, Francisco Llamas-Gutierrez, Marie Parrens
article en

Abstract

Correction to: Leukemiahttps://doi.org/10.1038/s41375-025-02777-2, published online 07 October 2025 In the originally published version of this article, same minor errors were present: (1) in Table 1, only the headers should appear in bold font, as now corrected; (2) in Figure 1B, two typographical errors occurred in panels c and d, where the correct legends are MEITL No 030 and MEITL No 039 instead of EATL No 030 and EATL No 039; (3) in Figure 3B, the MEITL CNV profile was mistakenly replaced by a duplication of the EATL profile. The correct MEITL profile has been now inserted; (4) in Figure 4F, the miRNA “577” label appeared in green font instead of black. All errors have been corrected in the revised figures and table provided in the updated version. Incorrect figure 1 (Figure presented.) Corrected figure 1 (Figure presented.) Incorrect figure 3 (Figure presented.) Corrected figure 3 (Figure presented.) Incorrect figure 4 (Figure presented.) Corrected figure 4 (Figure presented.) (Table presented.) MEITL (n = 52) EATL (n = 30) p value Reported celiac disease 0/52 (0%) 13/30 (43%) Age, median, years (range, median) 67 (29-91) 64 (34-86) 0.37 Gender (male/female) 27:25:00 19:11 0.2 Acute event at presentation 38/44 (86%) 12/18 (67%) 0.09 Bowel perforation 33/44 (75%) 8/18 (44%) Bowel obstruction 12/44 (27%) 6/18 (33%) 0.76 Lugano stage Stage I/II 27/44 (61%) 8/13 (61%) 1 Stage III/IV 17/44 (39%) 5/13 (39%) PS 0-1 18/40 (45%) 4/8 (50%) 1 ≥2 22/40 (55%) 4/8 (50%) Typical 31/52 (60%) Atypical 21/52 (40%) Pleomorphic 13/52 (25%) 30/30 (100%) Anaplastic 1/52 (2%) 15/30 (50%) Necrosis 7/52 (13%) 22/30 (73%) Starry-sky 5/52 (10%) 3/30 (10%) 1 Angiotropism 14/51 (27%) 19/29 (65%) Epitheliotropism 36/41 (88%) 2/20 (10%) Moderate/abundant inflammation 3/52 (6%) 20/30 (67%) CD8 47/52 (90%) 4/30 (13%) CD56 46/52 (88%) 2/28 (7%) CD3 52/52 (100%) 27/30 (90%) CD2 20/47 (42%) 12/24 (50%) 0.619 CD5 2/51 (4%) 2/30 (7%) 0.624 CD7 48/48 (100%) 22/23 (96%) 0.324 CD4 2/52 (4%) 2/27 (7%) 0.603 CD103 40/51 (78%) 15/25 (60%) 0.108 CD30 0/47 (0%) 25/29 (86%) TIA1 47/52 (90%) 20/25 (80%) 0.108 Granzyme B 37/52 (71%) 19/28 (68%) 0.596 Perforin 27/52 (52%) 22/29 (76%) CD20 9/49 (18%) 1/29 (3%) CD79a 3/41 (7%) 0/10 (0%) 0.567 TCRβ 17/50 (34%) 8/28 (29%) 0.472 TCRγδ 26/50 (52%) 8/27 (30%) TCRαβ-TCRγδ+ 22/49 (44%) 4/26 (15%) TCRαβ+TCRγδ- 12/49 (24%) 4/26 (15%) 0.391 TCRαβ+TCRγδ+ 4/49 (8%) 3/26 (11%) 0.685 TCRαβ-TCRγδ- 11/49 (22%) 15/26 (58%) The original article has been corrected.

LeukemiaVol. 40(1)
SIB Swiss Institute of Bioinformatics (CH), Université de Bordeaux (FR), Inserm (FR), University of Liège (BE), Université de Versailles Saint-Quentin-en-Yvelines (FR), Universität Ulm (DE), Université Paris-Est Créteil (FR), Université Paris Cité (FR), Aix-Marseille Université (FR), Institut Jules Bordet (BE), German Center for Pediatric and Adolescent Rheumatology (DE), Lille’s Cardiology Hospital (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Assistance Publique – Hôpitaux de Paris (FR), University of Clermont Auvergne (FR), Bordeaux Population Health (FR), Centre Hospitalier de Lens (FR), Hôpital Lyon Sud (FR), Centre Hospitalier du Mans (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Hôpitaux Universitaires Henri-Mondor (FR), Hôpital Ambroise-Paré (FR), Laboratoire National Henri Becquerel (FR), Lymphoma Study Association (FR), Institut Paoli-Calmettes (FR), Centre Hospitalier Universitaire de Rennes (FR), Institut Mondor de Recherche Biomédicale (FR), Centre International de Recherche en Infectiologie (FR), University of Tübingen (DE), University of Lausanne (CH)
Openalex Percentile: Top 50%
Celiac Disease Research and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.